CN115645482A - Philippine flemingia root and detoxication pill for preventing and treating cancer - Google Patents

Philippine flemingia root and detoxication pill for preventing and treating cancer Download PDF

Info

Publication number
CN115645482A
CN115645482A CN202211239560.3A CN202211239560A CN115645482A CN 115645482 A CN115645482 A CN 115645482A CN 202211239560 A CN202211239560 A CN 202211239560A CN 115645482 A CN115645482 A CN 115645482A
Authority
CN
China
Prior art keywords
herb
root
pill
preventing
philippine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202211239560.3A
Other languages
Chinese (zh)
Inventor
罗振
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202211239560.3A priority Critical patent/CN115645482A/en
Publication of CN115645482A publication Critical patent/CN115645482A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Qianjin detoxification pill for preventing and treating cancer, which is prepared from the following main raw materials in parts by weight: 20 g of philippine flemingia root, 15 g of paris polyphylla, 20 g of nux vomica, 12 g of lucid ganoderma, 20 g of solanum dulcamara, 20 g of snake mold, 20 g of black nightshade, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of philippine violet herb, 15 g of honeysuckle, 15 g of dahurian patrinia herb, 15 g of weeping forsythia, 20 g of astragalus root, 10 g of American ginseng, 10 g of safflower, 12 g of angelica, 10 g of szechuan lovage rhizome, 20 g of tuckahoe, 12 g of elephantopus scaber and 10 g of sinopodophyllum hexandrum. Compared with the prior art, the invention has the advantages that: the application is to treat various cancers by using a proper Chinese herbal medicine composition according to the principles of strengthening body resistance and banking up root, regulating qi and dredging, activating blood and dissolving stasis, reducing phlegm and clearing damp, clearing heat and detoxicating, softening hardness and dissipating stagnation and combating poison with poison.

Description

Philippine flemingia root and detoxication pill for preventing and treating cancer
Technical Field
The invention relates to the technical field of medicines, in particular to a philippine flemingia root and detoxication pill for preventing and treating cancers.
Background
Cancer is a local manifestation of systemic diseases, and has great harm to human health, and related data show that more than 200 million patients suffering from cancer in China each year, 160 million people die, the death rate accounts for 80%, and the most of the elderly people are the most. In recent years, the incidence of disease in middle-aged people has also begun to increase. The cause of death: the primary disease cannot be controlled by 40%; the rate of microscopic lesions is 60% of those that cannot be controlled, and more than 50% of patients have metastatic lesions at the time of diagnosis. In cancer, the incidence of esophageal cancer, cardia cancer, gastric cancer and lung cancer is high. For the treatment of cancer, the medical field usually adopts comprehensive treatment methods such as surgery, radiotherapy, chemotherapy and the like, and achieves certain results, but still has many defects. The traditional Chinese medicine therapy is an important means for treating cancer, and is widely determined by the medical community at present, because: the traditional Chinese medicine therapy can adjust the functions of organs of the body and mobilize various anti-cancer substances of the body, thereby not only improving the effects of other therapies, but also directly controlling and eliminating cancer cells, but also having higher cure rate, more stable effect and less medicaments, and having not ideal curative effect, such as the famous anti-cancer medicament 'Chinese ganoderma lucidum', the cancer disappearance rate of which is only 4 percent, and the inhibition rate of which on in-vitro tumor cells is only 50.9 percent, such as 'Tianxian pill' which is awarded in the world.
Disclosure of Invention
The invention aims to solve the technical problem of overcoming the technical defects and provides a Qianjin detoxification pill for preventing and treating cancer.
In order to solve the technical problems, the technical scheme provided by the invention is as follows: the Qianjin detoxification pill for preventing and treating the cancer is prepared from the following raw materials: 15-30 g of philippine flemingia root, 10-20 g of paris polyphylla, 15-25 g of glabrous greenbrier rhizome, 8-16 g of lucid ganoderma, 15-30 g of solanum dulcamara, 15-30 g of snake mould, 15-30 g of black nightshade, 10-25 g of barbed skullcap herb, 10-25 g of spreading hedyotis herb, 10-20 g of Chinese violet, 10-20 g of honeysuckle, 10-20 g of dahurian patrinia herb, 10-20 g of weeping forsythia capsule, 15-30 g of astragalus root, 6-15 g of American ginseng, 8-12 g of safflower, 8-15 g of angelica, 6-15 g of szechuan lovage rhizome, 15-25 g of tuckahoe, 8-16 g of scabrous elephantfoot herb and 6-15 g of podophyllum hexandrum.
Further, the traditional Chinese medicine composition is prepared from the following raw materials: 20 g of philippine flemingia root, 15 g of paris polyphylla, 20 g of nux vomica, 12 g of lucid ganoderma, 20 g of solanum dulcamara, 20 g of snake mold, 20 g of black nightshade, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of philippine violet herb, 15 g of honeysuckle, 15 g of dahurian patrinia herb, 15 g of weeping forsythia, 20 g of astragalus root, 10 g of American ginseng, 10 g of safflower, 12 g of angelica, 10 g of szechuan lovage rhizome, 20 g of tuckahoe, 12 g of elephantopus scaber and 10 g of sinopodophyllum hexandrum.
Furthermore, the raw materials are weighed according to the proportion, mixed, crushed and molded into small pills.
Compared with the prior art, the invention has the advantages that: the pill is a purely natural plant extract which can be used as both medicine and food, has the effects of efficiently preventing and treating cancers, avoids the side effect of liver injury induced by chemotherapeutic drugs, can treat various tumors, and mainly treats various cancers by using a proper Chinese herbal medicine formula according to the principles of strengthening body resistance and banking up root, regulating vital energy and dredging, activating blood and dissolving stasis, reducing phlegm and clearing damp, clearing heat and detoxicating, softening hardness and resolving hard mass and attacking poison with poison.
Detailed Description
The raw materials used in the formula of the invention all adopt common Chinese herbal medicines, and the medicine sources are rich and easy to obtain. The attributes and effects of the Chinese herbal medicine raw materials in the formula are as follows:
the Chinese philippine flemingia root: clear heat and remove toxicity, dispel wind and remove dampness. It is used to treat malaria, dysentery, rheumatalgia, edema, stranguria with turbid urine, sore throat, carbuncle, swelling, sore and furuncle.
Rhizoma paridis: mainly has the effects of diminishing inflammation, reducing swelling and disinfecting, is mainly used for trauma such as traumatic injury, blood stasis and red swelling, lumbar sprain, fracture and the like, and has curative effects.
And (4) buttonhseven: dispel stasis and promote tissue regeneration, alleviate pain and stop bleeding.
Ganoderma lucidum: the medicine has sweet and mild properties, enters heart, lung and kidney meridians, and has the effects of tonifying qi, soothing nerves, relieving cough and asthma.
White English: herba Solani Lyrati is bitter and slightly cold in nature, has effects of clearing heat and detoxicating, dispelling pathogenic wind and eliminating phlegm, dispelling pathogenic wind and removing dampness, and can be used for treating malaria, jaundice, edema, gonorrhea, rheumatic arthritis, and cholecystitis.
And (3) snake mildew: duchesnea indica has effects of clearing heat, cooling blood, relieving swelling and removing toxic substance.
Black nightshade: the black nightshade herb is slightly bitter and cold in property and has little toxicity, belongs to lung and bladder channels, and has the effects of clearing away heat and toxic materials, promoting blood circulation to reduce swelling and inducing diuresis.
Barbed skullcap herb: the traditional Chinese medicine sculellaria barbata is pungent, bitter and cold in taste and belongs to the channels of lung, liver and kidney.
Herba Hedyotidis Diffusae: the main effects are clearing away heat and toxic material, resolving carbuncle and dissipating binds, promoting urination and removing dampness, and the main clinical effects are to treat various inflammations.
Herba Violae: viola yedoensis Makino is bitter, pungent and cold in property, belongs to heat-clearing and detoxifying drugs, and has the effects of clearing heat, detoxifying, cooling blood and relieving swelling.
And (3) honeysuckle: the honeysuckle is a Chinese medicinal material. Cold in nature and sweet in taste. Has effects in clearing away heat and toxic materials, dispelling pathogenic wind and heat, cooling blood, and relieving dysentery.
Herba Patriniae: is dried whole plant of Patrinia villosa juss of Patrinia. Cool in nature, pungent and bitter in flavor.
And (3) fructus forsythiae: enters heart, lung and gallbladder meridians, and has effects of clearing away heat and toxic materials, resolving hard mass and resolving carbuncle.
Astragalus root: the traditional Chinese medicine astragalus belongs to deficiency tonifying medicines. Sweet in flavor and slightly warm in nature, they enter lung and spleen meridians.
American ginseng: it enters heart, lung and kidney meridians. Has the effects of invigorating qi, nourishing yin, clearing heat and promoting fluid production.
Safflower: safflower is pungent and warm in property, belongs to heart and liver meridians, belongs to blood-activating and menstruation-regulating medicines, and has the effects of activating blood and relieving dysmenorrheal, removing blood stasis and relieving pain.
Chinese angelica: the Chinese angelica is sweet, pungent and warm in property, belongs to liver, pungent and spleen meridians, is a traditional Chinese medicine for tonifying deficiency and enriching blood, and has the effects of enriching blood and promoting blood circulation, regulating menstruation and relieving pain, and relaxing bowel.
Ligusticum wallichii: the hemlock parsley is a medicine for activating blood and qi, has the functions of activating blood and qi, dispelling wind and relieving pain, is pungent and warm in nature and enters liver channels, gallbladder channels and pericardium channels.
Tuckahoe, poria cocos: induce diuresis to alleviate edema, poria is sweet and bland in flavor, with sweet flavor tonifying and bland flavor permeating, with mild property.
Radix seu herba Elephantopi scaberis: the efficacy of the elephantopus scaber has certain efficacy of clearing away heat and toxic materials.
And (3) Chinese pink: dispel wind-damp, relieve cough, alleviate pain, activate blood and remove toxicity.
Example 1
The Qianjin detoxification pill for preventing and treating the cancer is prepared from the following raw materials: 15-30 g of philippine flemingia root, 10-20 g of paris polyphylla, 15-25 g of paris polyphylla, 8-16 g of lucid ganoderma, 15-30 g of solanum dulcamara, 15-30 g of snake mold, 15-30 g of black nightshade, 10-25 g of barbed skullcap herb, 10-25 g of spreading hedyotis herb, 10-20 g of Chinese violet, 10-20 g of honeysuckle, 10-20 g of dahurian patrinia herb, 10-20 g of weeping forsythia capsule, 15-30 g of astragalus root, 6-15 g of American ginseng, 8-12 g of safflower, 8-15 g of Chinese angelica, 6-15 g of szechuan lovage rhizome, 15-25 g of Indian buead, 8-16 g of scabrous elephantfoot herb and 6-15 g of sinomenium hexandrum. Weighing the raw materials according to the proportion, mixing, crushing and molding to prepare the small pills.
Example 2
The traditional Chinese medicine composition is prepared from the following raw materials: 20 g of philippine flemingia root, 15 g of paris polyphylla, 20 g of nux vomica, 12 g of lucid ganoderma, 20 g of solanum dulcamara, 20 g of snake mold, 20 g of black nightshade, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of philippine violet herb, 15 g of honeysuckle, 15 g of dahurian patrinia herb, 15 g of weeping forsythia, 20 g of astragalus root, 10 g of American ginseng, 10 g of safflower, 12 g of angelica, 10 g of szechuan lovage rhizome, 20 g of tuckahoe, 12 g of elephantopus scaber and 10 g of sinopodophyllum hexandrum.
The raw materials are weighed according to the proportion, mixed, crushed and molded to prepare the pellet.
In 6 clinical application cases, all cases were lung cancer. Taken orally three times a day, 300ml each time. The taking time is 7-9 months, the effective rate of 4 cases is 66.7%, the effective rate of 1 case is significant, the effective rate of 16.7% and the ineffective rate of 2 cases is 33.3%.
The invention and its embodiments have been described above, without this being limitative. In summary, those skilled in the art should be able to conceive of the present invention without creative design of the similar structural modes and embodiments without departing from the spirit of the present invention, and all such modifications should fall within the protection scope of the present invention.

Claims (3)

1. The Qianjin detoxification pill for preventing and treating the cancer is characterized by being prepared from the following raw materials: 15-30 g of philippine flemingia root, 10-20 g of paris polyphylla, 15-25 g of paris polyphylla, 8-16 g of lucid ganoderma, 15-30 g of solanum dulcamara, 15-30 g of snake mold, 15-30 g of black nightshade, 10-25 g of barbed skullcap herb, 10-25 g of spreading hedyotis herb, 10-20 g of Chinese violet, 10-20 g of honeysuckle, 10-20 g of dahurian patrinia herb, 10-20 g of weeping forsythia capsule, 15-30 g of astragalus root, 6-15 g of American ginseng, 8-12 g of safflower, 8-15 g of Chinese angelica, 6-15 g of szechuan lovage rhizome, 15-25 g of Indian buead, 8-16 g of scabrous elephantfoot herb and 6-15 g of sinomenium hexandrum.
2. The philippine flemingia root and detoxication pill for preventing and treating cancer according to claim 1, which is characterized in that the traditional Chinese medicine composition is prepared from the following raw materials: 20 g of philippine flemingia root, 15 g of paris polyphylla, 20 g of nux vomica, 12 g of lucid ganoderma, 20 g of solanum dulcamara, 20 g of snake mold, 20 g of black nightshade, 20 g of barbed skullcap herb, 20 g of spreading hedyotis herb, 15 g of philippine violet herb, 15 g of honeysuckle, 15 g of dahurian patrinia herb, 15 g of weeping forsythia, 20 g of astragalus root, 10 g of American ginseng, 10 g of safflower, 12 g of angelica, 10 g of szechuan lovage rhizome, 20 g of tuckahoe, 12 g of elephantopus scaber and 10 g of sinopodophyllum hexandrum.
3. The philippine flemingia root and detoxication pill for preventing and treating cancer as claimed in claim 1, wherein the raw materials are weighed according to the above proportion, mixed, crushed and molded into small pills.
CN202211239560.3A 2022-10-11 2022-10-11 Philippine flemingia root and detoxication pill for preventing and treating cancer Withdrawn CN115645482A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211239560.3A CN115645482A (en) 2022-10-11 2022-10-11 Philippine flemingia root and detoxication pill for preventing and treating cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211239560.3A CN115645482A (en) 2022-10-11 2022-10-11 Philippine flemingia root and detoxication pill for preventing and treating cancer

Publications (1)

Publication Number Publication Date
CN115645482A true CN115645482A (en) 2023-01-31

Family

ID=84986601

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211239560.3A Withdrawn CN115645482A (en) 2022-10-11 2022-10-11 Philippine flemingia root and detoxication pill for preventing and treating cancer

Country Status (1)

Country Link
CN (1) CN115645482A (en)

Similar Documents

Publication Publication Date Title
CN102973893A (en) Traditional Chinese medicine combination for treating cancers
CN100409870C (en) Chinese traditional medicinal composition for treating psoriasis
CN115645482A (en) Philippine flemingia root and detoxication pill for preventing and treating cancer
CN103495103B (en) Medicament for promoting digestion and strengthening spleen
CN111150786A (en) Traditional Chinese medicine wine for treating scapulohumeral periarthritis and rheumatism and preparation method thereof
CN104623381A (en) Traditional-Chinese-medicine composition for treating skin disease caused by blood heat and liver depression
CN104623532A (en) Traditional Chinese medicine composition for treating glioma and preparation method thereof
CN105396019A (en) Pharmaceutical composition for relieving radiotherapy reaction of tumor patients
CN102166303B (en) Chinese medicinal composition for treating chronic atrophic gastritis
CN100534473C (en) Orally-administered traditional Chinese medicine composition for treating toothache
CN105412601A (en) Oral liquid used for resisting chemotherapy side reactions
CN104524535A (en) Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition
CN105688071A (en) Traditional Chinese medicine for treating interstitial lung disease
CN114668827A (en) Traditional Chinese medicine formula for conditioning and using method thereof
CN104984149B (en) A kind of drug used with Radiotherapy
CN104815008A (en) Traditional Chinese medicine powder for improving postoperative immune functions of tumor patients
CN116785382A (en) Medicinal liquor and preparation method thereof
CN113925947A (en) Traditional Chinese medicine formula for treating liver cancer
CN103341098B (en) Traditional Chinese medicine for treating tinea pedes
CN116999498A (en) Navel patch traditional Chinese medicine formula for treating dysmenorrhea
CN113679806A (en) Traditional Chinese medicine formula for treating spleen and stomach deficiency and toxin stasis internal accumulation type gastric cancer
CN110448587A (en) One kind embracing stone Xiaoaisan powder for curing cancer and preparation method thereof
CN111202831A (en) Pharmaceutical composition for treating primary liver cancer
CN113230377A (en) Traditional Chinese medicine electuary for treating wind-cold type common cold and preparation method thereof
CN114796372A (en) Double-vine whitening-removing pill

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20230131

WW01 Invention patent application withdrawn after publication